(The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s ...

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but it's expensive. Reading time 2 minutes To treat acute pain, doctors in the U ...

Ohio Gov. Mike DeWine recently banned the sale and use of nine synthetic opioids, compounds called nitazenes that are stronger than fentanyl, in the state. Theses man-made opioids were never approved ...

When combined with counseling and behavioral therapies, opioid use disorder medications are part of a comprehensive plan that supports long-term recovery. Opioid use disorder (OUD) occurs when ...